Publications by authors named "Keith Lange"

Valacyclovir, enzymatically hydrolyzed in the body to acyclovir, is a guanine-based nucleoside analog commonly prescribed as an antiviral therapy. Previous reports suggest that guanosine analogs bind to guanine deaminase; however, it is unclear whether they act as inhibitors or substrates. Data from our laboratory suggest that inhibition of guanine deaminase by small molecules attenuates spinal cord injury-induced neuropathic pain.

View Article and Find Full Text PDF
Article Synopsis
  • - SARS-CoV-2, the virus responsible for COVID-19, causes severe disease characterized by excessive inflammation, known as a "cytokine storm," leading to organ damage, particularly in the lungs.
  • - Research in a mouse model showed changes in the expression of drug transporters and metabolizing enzymes in the liver, kidneys, and lungs due to COVID-19, with some transporters being upregulated and others downregulated.
  • - The findings indicate a need for further research on how these changes in drug processing may affect the effectiveness of existing and new treatments for COVID-19 and how they impact the metabolism of natural compounds in the body.
View Article and Find Full Text PDF

Lymphatic filariasis is a debilitating illness with an estimated 50 million cases as of 2018. The majority of cases are caused by the parasitic worm W. bancrofti and additional cases by the worms B.

View Article and Find Full Text PDF

Cytosolic PSD-95 interactor (cypin) is a multifunctional, guanine deaminase that plays a major role in shaping the morphology of the dendritic arbor of hippocampal and cortical neurons. Cypin catalyzes the Zn-dependent deamination of guanine to xanthine, which is then metabolized to uric acid by xanthine oxidase. Cypin binds to tubulin heterodimers via its carboxyl terminal region (amino acids (aa) 350-454), which contains a collapsin response mediator protein (CRMP) homology domain (aa 350-403).

View Article and Find Full Text PDF

Filariasis is a tropical disease caused by the parasitic nematodes Wuchereria bancrofti and Brugia malayi. Known inhibitors of dihydrofolate reductase (DHFR) have been previously shown to kill Brugia malayi nematodes and to inhibit Brugia malayi DHFR (BmDHFR) at nanomolar concentrations. These data suggest that BmDHFR is a potential target for the treatment of filariasis.

View Article and Find Full Text PDF